Celularity Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Celularity

Access the complete profile.

Celularity Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	170 Park Avenue Florham Park, NJ 07932

Note: Revenues for privately held companies are statistical evaluations.


Celularity's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Celularity's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Celularity is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Celularity Annual Revenue and Growth Rate

Celularity	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Celularity's revenues are gauged from an analysis of company filings.

Celularity's Income Statement (based on Industry Averages)

Celularity P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Celularity has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
May 27, 2022	1	100%	$30 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Celularity is developing and marketing. Celularity doesn't have any recent trademark applications, indicating Celularity is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
AESTHETIC REGENERATIVE THERAPY (A.R.T.) Medical and cosmeceutical treatment of skin disease and aging using cells and biological tissue, namely, stem cells, umbilical cord tissue, umbilical cord blood, and placental-derived cells, placental tissue; medical services, namely, collection, testing, processing and preservation of human umbilical cord blood, stem cells, umbilical cords and placental tissue for medical use; isolation, collection, and banking of umbilical cord tissue, stem cells, umbilical cord blood, placental tissue, and placental-derived cells; medical services, namely, collection, testing, processing and preservation of clinically accessible, immune-tolerant human progenitor and other postpartum placenta-derived cell populations for medical and cosmeceutical treatment and diagnostics; medical and cosmeceutical treatment of skin disease and aging using methods to restore the structure and function of damaged or diseased tissues and organs, in particular wound care, reconstructive medicine, whole organ and tissue regeneration and renewal; medical and cosmeceutical treatment of skin disease and aging using emergent cell therapies; hair restoration treatments using cells and biological tissue, namely, stem cells, umbilical cords, umbilical cord blood, placental-derived cells and placental tissue; providing a web site featuring information relating to the aforementioned service	06/17/2022
CENTAPLAST Biological tissue for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds	02/10/2022
CENTAFIX Flowable and particulate material, namely, human placental biological connective tissue for the replacement or supplementation of damaged or inadequate integumental tissue	02/10/2022

See all trademarks and details in the Full Report.

Market Share of Celularity's Largest Competitors

A competitive analysis shows these companies are in the same general field as Celularity, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Celularity. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
ERG HOLDING	New Providence, NJ	100
ZELTIQ AESTHETICS	Madison, NJ	60
IMMUNOMEDICS	Morris Plains, NJ	37
ADC THERAPEUTICS AMERICA	New Providence, NJ	26
CELULARITY	Florham Park, NJ	24
COVIS PHARMA GMBH	Berkeley Heights, NJ	12

Future Competition: Celularity's Fastest Growing Competitors

These companies are in the same general field as Celularity and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)